British Journal of Cancer - Table of Contents alert Volume 119 Issue 11

Advertisement Researchoncology.com Explore the latest science, research, and clinical trials in hematology and oncology. TABLE OF CONTENTS Volume 119, Issue 11 In this issue Article Correspondence Also new AOP Article Effect of home-based specialised palliative care and dyadic psychological intervention on caregiver anxiety and depression: a randomised controlled trial Annika von Heymann-Horan, Pernille Bidstrup, Mai-Britt Guldin, Per Sjøgren, Elisabeth Anne Wreford Andersen et al. British Journal of Cancer 2018 119 :1307 - 1315; November 14, 2018; 10.1038/s41416-018-0193-8 Abstract | Full Text Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b Cameron E. Snell, Madeline Gough, Cheng Liu, Kathryn Middleton, Christopher Pyke et al. British Journal of Cancer 2018 119 :1316 - 1325; November 09, 2018; 10.1038/s41416-018-0331-3 Abstract | Full Text Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study Carmelo Tibaldi, Andrea Camerini, Marcello Tiseo, Francesca Mazzoni, Fausto Barbieri et al. British Journal of Cancer 2018 119 :1326 - 1331; November 08, 2018; 10.1038/s41416-018-0307-3 Abstract | Full Text SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer José Robles-Zurita, Kathleen A. Boyd, Andrew H. Briggs, Timothy Iveson, Rachel S. Kerr et al. British Journal of Cancer 2018 119 :1332 - 1338; November 13, 2018; 10.1038/s41416-018-0319-z Abstract | Full Text Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy Inês P. Santos, Remco van Doorn, Peter J. Caspers, Tom C. Bakker Schut, Elisa M. Barroso et al. British Journal of Cancer 2018 119 :1339 - 1346; November 09, 2018; 10.1038/s41416-018-0257-9 Abstract | Full Text Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer Bo-Kyung Kim, Soon Woo Nam, Byung Soh Min, Hyun Seung Ban, Soonmyung Paik et al. British Journal of Cancer 2018 119 :1347 - 1357; November 13, 2018; 10.1038/s41416-018-0289-1 Abstract | Full Text SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance Xiaodong Yuan, Jun Li, Cédric Coulouarn, Tao Lin, Laurent Sulpice et al. British Journal of Cancer 2018 119 :1358 - 1366; November 13, 2018; 10.1038/s41416-018-0338-9 Abstract | Full Text Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts Torben Frøstrup Hansen, Sanne Kjær-Frifeldt, Ann Christina Eriksen, Jan Lindebjerg, Lars Henrik Jensen et al. British Journal of Cancer 2018 119 :1367 - 1373; November 14, 2018; 10.1038/s41416-018-0285-5 Abstract | Full Text Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis Jing Qian, Kaja Tikk, Korbinian Weigl, Yesilda Balavarca & Hermann Brenner British Journal of Cancer 2018 119 :1374 - 1382; November 14, 2018; 10.1038/s41416-018-0280-x Abstract | Full Text The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer François Bertucci, Pascal Finetti, Ines Simeone, Wouter Hendrickx, Ena Wang et al. British Journal of Cancer 2018 119 :1383 - 1391; October 24, 2018; 10.1038/s41416-018-0309-1 Abstract | Full Text Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts Ádám Póti, Kinga Berta, Yonghong Xiao, Orsolya Pipek, Gregory T. Klus et al. British Journal of Cancer 2018 119 :1392 - 1400; November 14, 2018; 10.1038/s41416-018-0312-6 Abstract | Full Text Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes Darren R. Hodgson, Brian A. Dougherty, Zhongwu Lai, Anitra Fielding, Lynda Grinsted et al. British Journal of Cancer 2018 119 :1401 - 1409; October 24, 2018; 10.1038/s41416-018-0274-8 Abstract | Full Text Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival Alejandro Losada, María José Muñoz-Alonso, Marta Martínez-Díez, Federico Gago, Juan Manuel Domínguez et al. British Journal of Cancer 2018 119 :1410 - 1420; November 13, 2018; 10.1038/s41416-018-0336-y Abstract | Full Text Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study Vasily Giannakeas, Suzanne M. Cadarette, Joann K. Ban, Lorraine Lipscombe, Steven A. Narod et al. British Journal of Cancer 2018 119 :1421 - 1427; November 13, 2018; 10.1038/s41416-018-0225-4 Abstract | Full Text Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study Deependra Singh, Joonas Miettinen, Stephen Duffy, Nea Malila, Janne Pitkäniemi et al. British Journal of Cancer 2018 119 :1428 - 1435; November 07, 2018; 10.1038/s41416-018-0308-2 Abstract | Full Text Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts Yanan Ma, Wanshui Yang, Mingyang Song, Stephanie A. Smith-Warner, Juhong Yang et al. British Journal of Cancer 2018 119 :1436 - 1442; November 07, 2018; 10.1038/s41416-018-0314-4 Abstract | Full Text Correspondence Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis' Min Zhu, Ming Li, Jia Liu & Bin Lu British Journal of Cancer 2018 119 :1443 - 1443; November 09, 2018; 10.1038/s41416-018-0237-0 Abstract | Full Text Reply to 'Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis" Matejka Rebolj, Adam Brentnall & Stephen W. Duffy British Journal of Cancer 2018 119 :1444 - 1444; November 09, 2018; 10.1038/s41416-018-0247-y Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.